Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ikle

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|November 8, 2013
Induction regimens for ANCA-Associated VasculitisUlrich Specks, David Ikle, John H Stone
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2010
Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpointBrian C Healy, David Ikle, Eric A Macklin, et al.
Human Pathology|June 7, 2003
Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemiaDaniel A Arber, Nora H Carter, David Ikle, et al.
Human Pathology|December 24, 2003
Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markersKatharine C Chiu, Miriam Fine, David Ikle, et al.
American Journal of Clinical Pathology|February 28, 2002
Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocationsDaniel A Arber, Marilyn L Slovak, Leslie Popplewell, et al.
American Journal of Clinical Pathology|May 23, 2003
Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survivalDaniel A Arber, Anthony S Stein, Nora H Carter, et al.
The American Journal of Drug and Alcohol Abuse|December 31, 2004
Outcomes with the ARISE approach to engaging reluctant drug- and alcohol-dependent individuals in treatmentJudith Landau, M Duncan Stanton, David Brinkman-Sull, et al.
Pediatric Transplantation|December 17, 2015
Perceived barriers to medication adherence in pediatric and adolescent solid organ transplantationLara Danziger-Isakov, Thomas W Frazier, Sarah Worley, et al.
Pediatric Transplantation|July 24, 2019
Perceived barriers to medication adherence remain stable following solid organ transplantationLara Danziger-Isakov, Thomas W Frazier, Sarah Worley, et al.
Protein Engineering, Design & Selection : PEDS|August 19, 2004
Humanization of the anti-CEA T84.66 antibody based on crystal structure dataPaul J Yazaki, Mark A Sherman, John E Shively, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|November 8, 2013
Induction regimens for ANCA-Associated VasculitisUlrich Specks, David Ikle, John H Stone
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2010
Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpointBrian C Healy, David Ikle, Eric A Macklin, et al.
Human Pathology|June 7, 2003
Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemiaDaniel A Arber, Nora H Carter, David Ikle, et al.
Human Pathology|December 24, 2003
Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markersKatharine C Chiu, Miriam Fine, David Ikle, et al.
American Journal of Clinical Pathology|February 28, 2002
Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocationsDaniel A Arber, Marilyn L Slovak, Leslie Popplewell, et al.
American Journal of Clinical Pathology|May 23, 2003
Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survivalDaniel A Arber, Anthony S Stein, Nora H Carter, et al.
The American Journal of Drug and Alcohol Abuse|December 31, 2004
Outcomes with the ARISE approach to engaging reluctant drug- and alcohol-dependent individuals in treatmentJudith Landau, M Duncan Stanton, David Brinkman-Sull, et al.
Pediatric Transplantation|December 17, 2015
Perceived barriers to medication adherence in pediatric and adolescent solid organ transplantationLara Danziger-Isakov, Thomas W Frazier, Sarah Worley, et al.
Pediatric Transplantation|July 24, 2019
Perceived barriers to medication adherence remain stable following solid organ transplantationLara Danziger-Isakov, Thomas W Frazier, Sarah Worley, et al.
Protein Engineering, Design & Selection : PEDS|August 19, 2004
Humanization of the anti-CEA T84.66 antibody based on crystal structure dataPaul J Yazaki, Mark A Sherman, John E Shively, et al.
Pageof 3